Abstract
This chapter consists of two different topics which are extremely important in the toxicity of organophosphorus (OP) compounds. The first part is concerned with OP toxicity in humans. OPs cause four important neurotoxic effects, including the cholinergic syndrome, the intermediate syndrome, OP-induced delayed polyneuropathy, and chronic OP-induced neuropsychiatric disorder. Compared with the cholinergic syndrome, that causes millions of cases of poisoning with fatality of more than 15 % each year, other disorders involve much smaller number of patients. The second part describes the novel biomarker of OP exposure. Egasyn which is an isozyme of carboxylesterase is an accessory protein of β-glucuronidase (BG) in the liver microsomes. Egasyn-BG complex is located at the luminal site of liver microsomal endoplasmic reticulum membrane. When the OPs are incorporated into the liver microsomes, OP is tightly bound to egasyn, and subsequently, BG is dissociated and released into blood. Consequently, the increase of plasma BG activity is a good biomarker of OP exposure. The data presented in this chapter indicate the increase in plasma BG activity which is a much more sensitive biomarker to OP exposure than ChE (plasma cholinesterase) inhibition, particularly in the case of acute toxicity of OPs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abdollahi M, Karami-Mohajeri S (2012) A comprehensive review on experimental and clinical findings in intermediate syndrome caused by organophosphate poisoning. Toxicol Appl Pharmacol 258:309–314
Abou-Donia MB (1993) The cytoskeleton as a target for organophosphorus-ester-induced delayed neurotoxicity (OPIDN). Chem Biol Interact 87:383–393
Abou-Donia MB (2003) Organophosphorus ester-induced chronic neurotoxicity. Arch Environ Health 58:484–497
Ahmed GM, Davies DR (1997) Chronic organophosphate exposure: toward the definition of a neuropsychiatric syndrome. J Nutr Environ Med 7:169–176
Baker DJ, Sedgwick FM (1996) Single fiber electromyographic changes in man after organophosphate exposure. Hum Exp Toxicol 15:369–375
Balali-Mood M, Balali-Mood K (2008) Neurotoxic disorders of organophosphorous compounds and their managements. Arch Ir Med 11:65–89
Balali-Mood M, Saber H (2012) Recent advances in the treatment of organophosphorous poisonings. Iran J Med Sci 37:74–91
Bayrami M, Hashemi T, Malekirad AA, Ashayeri H, Faraji F, Abdollahi M (2012) Electroencephalogram, cognitive state, psychological disorders, clinical symptom, and oxidative stress in horticulture farmers exposed to organophosphate pesticides. Toxicol Ind Health 28:90–96
Bessler CL, Stallones L (2008) A cohort study of pesticide poisoning and depression in Colorado farm residents. Ann Epidemiol 18:768–774
Chang PA, Wu YJ (2010) Neuropathy target esterase: an essential enzyme for neural development and axonal maintenance. Int J Biochem Cell Biol 42:573–575
Clark RF (2002) Insecticides: organic phosphorus compounds and carbamates. In: Goldfrank’s toxicological emergencies, 7th ed. McGraw-Hill Professional, New York, pp 1346–1360
Davies R, Ghouse A, Tegwedd F (2000a) Chronic exposure to organophosphates: background and clinical picture. Adv Psychiatr Treat 6:187–192
Davies R, Ghouse A, Tegwedd F (2000b) Psychiatric aspects of chronic exposure to organophosphates: diagnosis and management. Adv Psychiatr Treat 6:356–361
De Bleecker J (1995) The intermediate syndrome in organophosphate poisoning: an overview of experimental and clinical observations. J Toxicol Clin Toxicol 33:683–686
De Bleecker JL (2006) Intermediate syndrome in organophosphate poisoning. In: Gupta RC (ed) Toxicology of organophosphate and carbamate compounds, Chapter 26. Elsevier Academic Press, Amsterdam, pp 371–380
De Bleecker J, Van DNeuckerK, Colardyn F (1993) Intermediate syndrome in organophosphorus poisoning: a prospective study. Crit Care Med 21:1706–1711
De Silva HJ, Samarawickrema NA, Wickremasinghe AR (2006) Toxicity due to organophosphorus compounds: what about chronic exposure? Trans Roy Soc Trop Med Hyg 100:803–806
Desi I, Nagymajtenyi L (1999) Electrophysiological biomarkers of an organophosphorous pesticide, dichlorvos. Toxicol Lett 107:55–64
Eddleston M (2000) Patterns and problems of deliberate self-poisoning in the developing world. QJM 93:715–731
Eddleston M, Phillips MR (2004) Self-poisoning with pesticides. Brit Med J 328:42–44
Eddleston M, Juszczak E, Buckley NA, Senarathna L, Mohamed F, Dissanayake W, Hittarage A, Azhe S, Jeganathan K, Jayamanne S, Sheriff MHR, Warrell DA (2008) Multiple-dose activated charcoal in acute self-poisoning: a randomised controlled trial. Lancet 371:579–587
Emerick GL, Peccinini RG, de Oliveira GH (2010) Organophosphorus-induced delayed neuropathy: a simple and efficient therapeutic strategy. Toxicol Lett 192:238–244
Emerick GL, De Oliveira GH, dos Santos AC, Ehrich M (2012) Mechanisms for consideration for intervention in the development of organophosphorus-induced delayed neuropathy. Chem Biol Interact 199:177–184
Fujikawa Y, Satoh T, Suganuma A, Suzuki S, Niikura Y, Yui S, Yamaura Y (2005) Extremely sensitive biomarker of acute organophosphorus insecticide exposure. Hum Exp Toxicol 24:1–4
Glynn P (2006) A mechanism for organophosphate-induced delayed neuropathy. Toxicol Lett 162:94–97
Hernandez FA, Gomez AM, Pena G, Gil F, Rodrigo L, Villanueva E, Pla A (2004) Effect of long-term to pesticides on plasma esterases from plastic greenhouse workers. J Toxicol Environ Health 67:1095–1108
Hosokawa M, Maki T, Satoh T (1990) Characteriztion of molecular spcies of liver microsomal carboxylesterases of several animal species and humans. Arch Biochem Biophys 277:219–227
Inayat-Hussain SH, Lubis SH, Ghazali R, Sakian NI, Ghazali AR, Ali NS, Sersi EM, Lee MT, Zainab AM, Hashim S, Ghazali MS, Saidin MN, Ab Rahman AR, Rafaai MJM, Omar S, Rapiai R, Othman R, Chan TL, Johari A, Soon WH, Salleh AR, Satoh T (2007) Is beta-glucuronidase a novel biomarker for anticholinesterase poisoning? A Malaysian experience. Toxicol Appl Pharmacol 219(2–3):210–216
IPCS (1998) Organophosphorus pesticides. International Programme on Chemical Safety Poisons Information Monograph G001, World Health Organization, Geneva, 1989; updated 1998. http://www.inchem.org/documents/pims/chemical/pimg001.htm
Jaga K, Dharmani C (2007) The interrelation between organophosphate toxicity and the epidemiology of depression and suicide. Rev Environ Health 22:57–73
Jamal GA (1997) Neurological syndromes of organophosphorus compounds. Adverse Drug React Toxicol Rev 16:133–170
Jamal HH, Noor HI, Syarif HL, Syed Mohd SA, Noraziah D (1995) Health effects related to pesticide use among paddy farmers of the Muda area in Kedah. In MINT-MADA (Muda Agricultural Development Authority), Malaysia
Jayawardane P, Senanayake N, Dawson A (2009) Electrophysiological correlates of intermediate syndrome following acute organophosphate poisoning. Clin Toxicol 47:193–205
Jeyaratnam J (1990) Pesticide poisoning: a major global health problem. World Health Statist. Quart 43:139–144
John M, Oommen A, Zachariah A (2003) Muscle injury in organophosphorous poisoning and its role in the development of intermediate syndrome. Neurotoxicology 24:43–53
Johnson MK (1982) The target for initiation of delayed neurotoxicity by organophosphorus esters: biochemical studies and toxicological applications. In: Hodgson E, Bend JR, Philpot RM (eds) Reviews in biochemical toxicology, Vol 4. Elsevier, New York, pp 141–212
Jokanović M (2001) Biotransformation of organophosphorus compounds. Toxicology 166:139–160
Jokanović M (2009a) Medical treatment of acute poisoning with organophosphorus and carbamate pesticides. Toxicol Lett 190:107–115
Jokanović M (2009b) Neuropathy: chemically-induced. In: Squire L, Albright T, Bloom F, Gage F, Spitzer N (eds) Encyclopedia of neuroscience, Chapter 515. Elsevier, pp 759–765
Jokanović M (2012a) Neurotoxic disorders and medical management of patients poisoned with organophosphorus and carbamate pesticides. In: Jokanović M (ed) The impact of pesticides. Academic Publishers, pp. 39–62
Jokanović M (2012b) Structure-activity relationship and efficacy of pyridinium oximes in the treatment of poisoning with organophosphorus compounds: a review of recent data. Curr Top Med Chem 12:1775–1789
Jokanović M, Kosanović M (2010) Neurotoxic effects in patients poisoned with organophosphorus pesticides. Environ Toxicol Pharmacol 29:195–201
Jokanović M, Prostran M (2009) Pyridinium oximes as cholinesterase reactivators. Structure-activity relationship and efficacy in the treatment of poisoning with organophosphorus compounds. Curr Med Chem 16:2177–2188
Jokanović M, Stojiljković MP (2006) Current understanding of the application of pyridinium oximes as cholinesterase reactivators in treatment of organophosphate poisoning. Eur J Pharmacol 553:10–17
Jokanović M, Stukalov PV, Kosanović M (2002) Organophosphate induced delayed polyneuropathy. Curr Drug Targets CNS Neurol Disord 1:591–600
Jokanović M, Kosanović M, Stukalov PV (2004) Organophosphate induced delayed polyneuropathy. Med Chem Rev—Online 1:123–131
Jokanović M, Antonijević B, Vučinić S (2010) Epidemiological studies of anticholinesterase pesticide poisoning in Serbia. In: Satoh T, Gupta RC (eds) Anticholinesterase pesticides: metabolism, neurotoxicity and epidemiology, Chapter 35, Wiley, pp 481–494
Jokanović M, Kosanović M, Brkić D, Vukomanović P (2011) Organophosphate induced delayed polyneuropathy in man: an overview. Clin Neurol Neurosurg 113:7–10
Kale BS (2012) Creatine kinase and lactate dehydrogenase as markers of muscular damage in intermediate syndrome associated with organophosphorus toxicity. Indian Streams Res J 2:1–6
Kamel F, Hoppin JA (2004) Association of pesticide exposure with neurologic dysfunction and disease. Environ Health Perspect 112:950–958
Karalliedde L, Baker D, Marrs T (2006) Organophosphate-induced intermediate syndrome: aetiology and relationships with myopathy. Toxicol Rev 25:1–14
Karchmar AG (2007) Anticholinesterases and war gases. In: Karchmar AG (ed) Exploring the vertebrate central cholinergic nervous system, Chapter 7. Springer, pp 237–310
Kaur P, Radotra B, Minz RW, Gill KD (2007) Impaired mitochondrial energy metabolism and neuronal apoptotic cell death after chronic dichlorvos (OP) exposure in rat brain. Neurotoxicology 26:1208–1219
Kikuchi H, Suzuki Y, Hashimoto Y (1981) Increase of beta-glucuronidase activity in the serum of rats administered organophosphate and carbamate insecticides. J Toxicol Sci 6:27–35
Kohen GL, Henderson G, Karczmar AG (1980) Di-isopropyl phosphofluoridate induced antinociception: possible role of endogenous opioids. Eur J Pharmacol 61:167–173
Kubek MJ, Shih TM, Meyerhoff JL (1997) Thyrotropin-releasing hormone (TRH) is markedly increased in the rat brain following soman-induced convulsions. Brain Res 747:328–331
Levin HS, Rodnitzky RL, Mick DL (1976) Anxiety associated with exposure to organophosphorus compounds. Arch Gen Psychiatr 33:225–228
London L, Nell V, Thompson ML, Myers JE (1998) Effects of long term organophosphate exposures on neurological symptoms, vibration sense and tremor among South African farm workers. Scand J Work Environ Health 24:18–29
London L, Flisher AJ, Wesseling C, Mergler D, Kromhout H (2005) Suicide and exposure to organophosphate pesticides: cause or effect? Am J Ind Med 47:308–321
Lotti M (1992) The pathogenesis of organophosphate delayed polyneuropathy. Crit Rev Toxicol 21:465–487
Lotti M, Moretto A (2005) Organophosphate-induced delayed polyneuropathy. Toxicol Rev 24:37–49
Lubis SH, Uttaman A, Nezrul Hisham AG, Jamil MRM, Salmaan Hussain IH (2002) The current perception threshold among rice farmers in Muda, Kedah and Fishermen in Setiu, Terengganu. In: Nashriyah BM, Ho NK, Ismail BS, Ali AB, Lum KY, Mansor MB (eds) Sustainable rice production in Malaysia beyond 2000. MINTMADA, Malaysia
Marrs TC, Vale JA (2006) Management of organophosphorus pesticide poisoning. In: Gupta RC (ed) Toxicology of organophosphorus and carbamate compounds, Chapter 49. Elsevier Academic Press, Amsterdam, pp 715–733
Medda S, Takeuchi K, Devore-arter D, Con Deimling O, Heymann E, Swank RT (1987) An accessory protein identical to mouse egasyn in complexed with rat β-glucuronidase and is identical to rat esterase 3. J Biol Chem 262:7248–7253
Morgan JP (1982) The Jamaica ginger paralysis. J Am Med Assoc 248:1864–1867
Nutley B, Cocker J (1993) Biological monitoring of workers occupationally exposed to organophosphorus pesticides. Pest Sci 38:315–322
O’Malley MA (2007) Pesticide. In: LaDou J (ed) Current occupational & environmental medicine, 4th ed. McGraw-Hill, New York, p 544
Parron T, Hernandez AF, Pla A, Villanueva E (1996) Clinical and biochemical changes in greenhouse sprayers chronically exposed to pesticides. Hum Exp Toxicol 12:957–963
Paul N, Mannathukkaran TJ (2005) Intermediate syndrome following carbamate poisoning. Clin Toxicol 43:867–868
Pope CN (2006) Central nervous system effects and neurotoxicity. In: Gupta RC (ed) Toxicology of organophosphate and carbamate compounds, Chapter 20. Elsevier Academic Press, Amsterdam, pp 271–291
Pope CN, Chakraborti TK, Chapman ML, Farrar JD (1992) Long-term neurochemical and behavioral effects induced by chlorpyrifos treatment. Pharmacol Biochem Behav 42:251–256
Ray DE (1998) Chronic effects of low level exposure to anticholinesterases—a mechanistic review. Toxicol Lett 102–103:527–533
Ray DE, Richards PG (2001) The potential for toxic effects of chronic, low-dose exposure to organophosphates. Toxicol Teratol 120:343–351
Read DJ, Li Y, Chao MV, Cavanagh JB, Glynn P (2009) Neuropathy target esterase is required for adult vertebrate axon maintenance. J Neurosci 29:11594–11600
Reiner E, Pleština R (1979) Regeneration of cholinesterase activities in humans and rats after inhibition by O, O-dimethyl-O-dimethyl-2,2-dichlorvinyl phosphate. Toxicol Appl Pharmacol 49:451–454
Richardson RJ, Hein ND, Wijeysakere SJ, Fink JK, Makhaeva GF (2012) Neuropathy targer esterase (NTE): overview and future. Chem Biol Interact. http://dx.doi.org/10.1016/j.cbi.2012.10.24
Rohlman DS, Anger WK, Lein PJ (2011) Correlating neurobehavioral performance with biomarkers of organophosphorous pesticide exposure. Neurotoxicology 32:268–276
Roldan-Tapia L, Parron T, Sanchez-Santed F (2005) Neuropsychological effects of long-term exposure to organophosphate pesticides. Neurotoxicol Teratol 27:259–266
Rosenstock L, Keifer M, Daniell W, McConnell R, Claypoole K (1991) Chronic central nervous system effects of acute organophosphate pesticide intoxication. Lancet 338:223–227
Ross SM, McManus IC, Harrison V, Mason O (2013) Neurobehavioral problems following low-level exposure to organophosphate pesticides: a systematic and meta-analytic review. Crit Rev Toxicol 43:21–44
Ruckart PZ, Kakolewski K, Bove FJ, Kaye WE (2004) Long-term neurobehavioral health effects of methyl parathion exposure in children in Mississippi and Ohio. Environ Health Perspect 112:46–51
Sabbe MB, Desruelles D, Lissens W (2008) Is β-glucuronidase a clinical useful biomarker for an acute organophosphorus poisoning? Hum Exp Tox 27:431–433
Salvi RM, Lara DR, Ghisolfi ES, Portela LV, Dias RD, Souza DO (2003) Neuropsychiatric evaluation in subjects chronically exposed to organophosphate pesticides. Toxicol Sci 72:267–271
Satoh T, Hosokawa M (1998) The mammalian carboxylesterases: from molecules to functions. Ann Rev Pharmacol Toxicol 38:257–288
Satoh T, Hosokawa M (2000) Organophosphates and their impact on the global environment. Neurotoxicology 21:223–227
Satoh T, Suzuki S, Kawai N, Nakamura T, Hosokawa M (1999) Toxicological significance in the cleavage of esterase-beta-glucuronidase complex in liver microsomes by organophosphorus compounds. Chem-Biol Interact 14(119–120):471–478
Satoh T, Taylor P, Bosron WF, Sanghani SP, Hosokawa M, La Du B (2002) Current progress on esterases: from molecular structure to function. Drug Metab Dispos 30:488–493
Savage EP, Keefe TJ, Mounce LM, Heaton RK, Lewis JA, Burcar PJ (1998) Chronic neurological sequelae of organophosphate pesticide poisoning. Arch Environ Health 43:38–45
Senanayake N, Karalliedde L (1987) Neurotoxic effects of organophosphorus insecticides: an intermediate syndrome. New Engl J Med 316:761–763
Singh S, Sharma N (2000) Neurological syndromes following organophosphate poisoning. Neurol India 48:308–313
Soltaninejad K, Shadnia S, Afkhami-Taghipour M, Saljooghi R, Mohammadirad A, Abdollahi M (2007) Blood beta-glucuronidase as a suitable biomarker at acute exposure of severe organophosphorus poisoning in human. Hum Exp Toxicol 26:963–966
Steenland K, Jenkins B, Ames RG, O’Maley M, Chrislip D, Russo J (1994) Chronic neurological sequelae to organophosphate poisoning. Am J Pub Health 84:731–736
Tan DH, Peng SQ, Wu YL, Wang YM, Lu CF, Yan CH (2009) Chronic organophosphate (OP)-induced neuropsychiatric disorder is a withdrawal syndrome. Med Hypotheses 72:405–406
van Dongen CJ, Wolthuis OL (1989) On the development of behavioral tolerance to organophosphates. I: behavioral and biochemical aspects. Pharmacol Biochem Behav 34:473–481
van derHW, Konradsen F, Athukorala K, Wanigadewa T (1998) Pesticide poisoning: a major health problem in Sri Lanka. Soc Sci Med 46:495–504
Worek F, Diepold C, Eyer P (1999) Dimethylphosphoryl-inhibited human cholinesterases: inhibition, reactivation, and aging kinetics. Arch Toxicol 73:7–14
World Health Organization (1986) Organophosphorus insecticides: a General introduction, vol 63. Environmental Health Criteria, Geneva
Yang C-C, Deng J-F (2007) Intermediate syndrome following organophosphate insecticide poisoning. J Chin Med Assoc 70:467–472
Acknowledgements
M. Jokanović, was supported in part by the Ministry of Education, Science and Technology of the Republic of Serbia (Project 175045).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag London
About this chapter
Cite this chapter
Satoh, T., Jokanović, M. (2014). Toxicity and Novel Biomarkers of OP Exposure. In: Balali-Mood, M., Abdollahi, M. (eds) Basic and Clinical Toxicology of Organophosphorus Compounds. Springer, London. https://doi.org/10.1007/978-1-4471-5625-3_5
Download citation
DOI: https://doi.org/10.1007/978-1-4471-5625-3_5
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-5624-6
Online ISBN: 978-1-4471-5625-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)